The UK head of immunization, Dr. David Salisbury, wrote today to the Guardian that the decision had been taken to add adjuvants to the H1N1 vaccine, if the virus mutates. Salisbury claims this would offer cross-protection.
It might, but it might not. Until the virus mutates you won't know.
Salisbury contends that, "the UK has robust surveillance in place for early detection of any adverse events." Kudos for this plan. Please let the public know what is found.